Home » EU Agency Backs Zeltia Drug for Ovarian Cancer
EU Agency Backs Zeltia Drug for Ovarian Cancer
Shares in Spain’s Zeltia soared after advisors to European regulators recommended the loss-making pharmaceutical firm’s Yondelis drug for use in the treatment of ovarian cancer.
Forbes
Forbes
Upcoming Events
-
07May
-
14May
-
30May